文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

瑞德西韦与环糊精的包合作用:抗冠状病毒耐药性的全面综述——现状与未来展望。

Inclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance-Current State and Future Perspectives.

机构信息

PG and Research Department of Chemistry, Government Arts College, Chidambaram 608 102, Tamil Nadu, India.

School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.

出版信息

Molecules. 2024 Oct 9;29(19):4782. doi: 10.3390/molecules29194782.


DOI:10.3390/molecules29194782
PMID:39407710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477750/
Abstract

Cyclodextrin (CD) derivatives have gained significant attention in biomedical applications due to their remarkable biocompatibility, unique inclusion capabilities, and potential for functionalization. This review focuses on recent advancements in CD-based assemblies, specifically their role in improving drug delivery, emphasizing remdesivir (RMD). The review introduces CD materials and their versatile applications in self-assembly and supramolecular assembly. CD materials offer immense potential for designing drug delivery systems with enhanced activity. Their inherent inclusion capabilities enable the encapsulation of diverse therapeutic agents, including RMD, resulting in improved solubility, stability, and bioavailability. The recent advances in CD-based assemblies, focusing on their integration with RMD have been concentrated here. Various strategies for constructing these assemblies are discussed, including physical encapsulation, covalent conjugation, and surface functionalization techniques. Furthermore, exploring future directions in these fields has also been provided. Ongoing research efforts are directed toward developing novel CD derivatives with enhanced properties, such as increased encapsulation efficiency and improved release kinetics. Moreover, the integration of CD-based assemblies with advanced technologies such as nanomedicine and gene therapy holds tremendous promise for personalized medicine and precision therapeutics.

摘要

环糊精(CD)衍生物由于其出色的生物相容性、独特的包合能力以及功能化的潜力,在生物医学应用中引起了广泛关注。本综述重点介绍了基于 CD 的组装体的最新进展,特别是它们在改善药物传递中的作用,强调了瑞德西韦(RMD)的应用。本综述介绍了 CD 材料及其在自组装和超分子组装中的多种应用。CD 材料为设计具有增强活性的药物传递系统提供了巨大的潜力。它们固有的包合能力使各种治疗剂(包括 RMD)的封装成为可能,从而提高了溶解度、稳定性和生物利用度。这里集中讨论了基于 CD 的组装体的最新进展,重点是它们与 RMD 的整合。讨论了构建这些组装体的各种策略,包括物理包封、共价键合和表面功能化技术。此外,还提供了对这些领域未来方向的探索。目前的研究工作集中于开发具有增强性能的新型 CD 衍生物,例如提高包封效率和改善释放动力学。此外,将 CD 基组装体与纳米医学和基因治疗等先进技术集成,为个性化医学和精准治疗提供了巨大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/62f8292aa7a5/molecules-29-04782-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/5036101e5fbc/molecules-29-04782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/b7675b6c05f6/molecules-29-04782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/33af781c83f8/molecules-29-04782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/3e22d059cc9f/molecules-29-04782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/bd22a162b01b/molecules-29-04782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/33aa4d916915/molecules-29-04782-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/bd5f7be41a7a/molecules-29-04782-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/62f8292aa7a5/molecules-29-04782-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/5036101e5fbc/molecules-29-04782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/b7675b6c05f6/molecules-29-04782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/33af781c83f8/molecules-29-04782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/3e22d059cc9f/molecules-29-04782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/bd22a162b01b/molecules-29-04782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/33aa4d916915/molecules-29-04782-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/bd5f7be41a7a/molecules-29-04782-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58f/11477750/62f8292aa7a5/molecules-29-04782-g008.jpg

相似文献

[1]
Inclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance-Current State and Future Perspectives.

Molecules. 2024-10-9

[2]
What Do We Know About Remdesivir Drug Interactions?

Clin Transl Sci. 2020-9

[3]
On the molecular structure of Remdesivir for the treatment of Covid-19.

Comput Methods Biomech Biomed Engin. 2021-7

[4]
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.

Rev Med Virol. 2020-7-30

[5]
Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.

Biochem Pharmacol. 2021-1

[6]
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.

Emerg Microbes Infect. 2021-12

[7]
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment.

Drug Res (Stuttg). 2021-3

[8]
Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective.

Adv Drug Deliv Rev. 2013-5-11

[9]
A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.

Mini Rev Med Chem. 2021

[10]
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.

Protein J. 2020-11-13

引用本文的文献

[1]
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics.

Pharmaceutics. 2025-2-22

本文引用的文献

[1]
Remdesivir: A Review in COVID-19.

Drugs. 2023-9

[2]
Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir.

Fundam Clin Pharmacol. 2023-8

[3]
Veklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content.

Br J Pharmacol. 2023-8

[4]
A Review of Cyclodextrin Encapsulation and Intelligent Response for the Release of Curcumin.

Polymers (Basel). 2022-12-11

[5]
A novel and water-soluble material for coronavirus inactivation from oseltamivir in the cavity of methyl and sulfated-β-cyclodextrins through inclusion complexation.

J Pharm Biomed Anal. 2022-11-30

[6]
Integration of cyclodextrins and associated toxicities: A roadmap for high quality biomedical applications.

Carbohydr Polym. 2022-11-1

[7]
Molecular docking assisted exploration on solubilization of poorly soluble drug remdesivir in sulfobutyl ether-tycyclodextrin.

AAPS Open. 2022

[8]
The determination of Sulfobutylether β-Cyclodextrin Sodium (SBECD) by LC-MS/MS and its application in remdesivir pharmacokinetics study for pediatric patients.

J Pharm Biomed Anal. 2022-4-1

[9]
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients.

Med Sci Monit. 2022-1-1

[10]
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.

N Engl J Med. 2022-2-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索